Stock Events
Stock Events
Search...
Features
Business
Blog
Help
Learn
Get App
Login
Sign Up
Get App
Ligand Pharmaceuticals (LGND) Q2 2021 Earnings
LGND
3
May
Confirmed
Q3 2020
Q4 2020
Q1 2021
Q2 2021
0.76
1.05
1.33
1.62
Details
Expected EPS
1.14
Actual EPS
1.41
Surprise EPS
0.27
Surprise Percent
+23.68%
Description
Ligand Pharmaceuticals (LGND) has reported earnings of 1.41 per share for Q2 2021.
0 Comments
Share your thoughts
Get the Stock Events App
Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.
Sign Up
Login
Home
Timeline
Search
Watchlist